605266 JZJ Chain Drugstore Corporation
- 20.54
- -0.28-1.34%
JZJ Chain Drugstore Corporation News
Announcement on the Results of Stock Repurchase Implementation and Share Changes.
Announcement Regarding Additional Pledging of Shares by the Actual Controller of the Company
Announcement of the results of the restricted stock incentive plan granted in 2024.
Announcement on the Progress of Repurchasing Shares through the Centralized Bidding Trading Method.
Announcement Regarding the Company's First Stock Repurchase through Centralized Competitive Trading Method.
Report on Repurchasing Shares by means of Centralized Bidding Trading
Announcement on the plan of repurchasing shares through centralized bidding trade method.
Legal opinion of Deheng (Kunming) Law Firm on the achievement of the first release of restrictions on the grant of the third phase of the restricted stock incentive plan of Yunnan Jianzhijia Health-Chain Pharmaceutical Chain Group Co., Ltd. in 2021.
Announcement on the First Release of Restricted Stock Incentive Plan for 2021 and Unlocking of Restricted Stocks in the Third Phase.
Announcement Regarding Additional Pledging of Shares by the Actual Controller of the Company
Announcement regarding the adjustment of the quantity and price of restricted stocks in the company's 2024 stock incentive plan and the granting of restricted stocks to incentive recipients.
Legal opinion of Deheng (Kunming) Law Firm on the adjustment and award of restricted stocks incentive plan of Yunnan Jianzhijia Health-Chain Group Co., Ltd. in 2024.
Announcement on adjusting the number and repurchase price of the first restricted stock incentive plan granted in 2021 and repurchasing and canceling a portion of the restricted stocks.
Legal opinion of Beijing Deheng (Kunming) Law Firm on Yunnan Jianzhijia Health-Chain Pharmaceutical Chain Group Co., Ltd.'s adjustment of the first repurchase quantity and repurchase price of the third phase of the initial grant of restricted stock incentives in 2021 and repurchase cancellation of part of the restricted stocks.
Announcement on the Completion of the Performance Commitment by Hebei Tangren Pharmaceutical Co., Ltd. and the Completion of the Original Equity Acquisition Plan by the Company.
Announcement on the extension of share pledges for shareholders holding 5% or more of the shares
Jianzhijia Pharmaceutical Chain Group Co., Ltd. 2023 Annual Equity Distribution Implementation Notice
Announcement on the progress of Hebei Tangren Pharmaceutical Co., Ltd. continuing to advance the original share acquisition plan after completing the performance promise
Self-inspection report on the 2024 Restricted Stock Incentive Plan insider information informants and incentive recipients trading the company's stock
Announcement on shareholders' share reduction plans
Analysis
Price Target
No Data
